# Quantifying the Presence of Lung Disease and Pulmonary Hypertension in Children With Sickle Cell Disease

> **NCT01895998** · PHASE1 · COMPLETED · sponsor: **Duke University** · enrollment: 5 (actual)

## Conditions studied

- Sickle Cell Disease

## Interventions

- **DRUG:** Albuterol

## Key facts

- **NCT ID:** NCT01895998
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08
- **Primary completion:** 2014-04
- **Final completion:** 2014-04
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2014-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01895998

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01895998, "Quantifying the Presence of Lung Disease and Pulmonary Hypertension in Children With Sickle Cell Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01895998. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*